These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22735378)

  • 1. Safe, long-term hepatic expression of anti-HCV shRNA in a nonhuman primate model.
    Suhy DA; Kao SC; Mao T; Whiteley L; Denise H; Souberbielle B; Burdick AD; Hayes K; Wright JF; Lavender H; Roelvink P; Kolykhalov A; Brady K; Moschos SA; Hauck B; Zelenaia O; Zhou S; Scribner C; High KA; Renison SH; Corbau R
    Mol Ther; 2012 Sep; 20(9):1737-49. PubMed ID: 22735378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro characterization of the activity of PF-05095808, a novel biological agent for hepatitis C virus therapy.
    Lavender H; Brady K; Burden F; Delpuech-Adams O; Denise H; Palmer A; Perkins H; Savic B; Scott S; Smith-Burchnell C; Troke P; Wright JF; Suhy D; Corbau R
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1364-75. PubMed ID: 22203606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stable replication of the EBNA1/OriP-mediated baculovirus vector and its application to anti-HCV gene therapy.
    Suzuki H; Matsumoto N; Suzuki T; Chang MO; Takaku H
    Virol J; 2009 Oct; 6():156. PubMed ID: 19796392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of hepatitis C virus infection and expression in vitro and in vivo by recombinant adenovirus expressing short hairpin RNA.
    Sakamoto N; Tanabe Y; Yokota T; Satoh K; Sekine-Osajima Y; Nakagawa M; Itsui Y; Tasaka M; Sakurai Y; Cheng-Hsin C; Yano M; Ohkoshi S; Aoyagi Y; Maekawa S; Enomoto N; Kohara M; Watanabe M
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1437-47. PubMed ID: 17683479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of hepatitis C virus replicon by RNA interference directed against the NS3 and NS5B regions of the viral genome.
    Takigawa Y; Nagano-Fujii M; Deng L; Hidajat R; Tanaka M; Mizuta H; Hotta H
    Microbiol Immunol; 2004; 48(8):591-8. PubMed ID: 15322339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons.
    Jarczak D; Korf M; Beger C; Manns MP; Krüger M
    FEBS J; 2005 Nov; 272(22):5910-22. PubMed ID: 16279954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of hepatitis C virus replication using adeno-associated virus vector delivery of an exogenous anti-hepatitis C virus microRNA cluster.
    Yang X; Haurigot V; Zhou S; Luo G; Couto LB
    Hepatology; 2010 Dec; 52(6):1877-87. PubMed ID: 20931557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative approaches for efficient inhibition of hepatitis C virus RNA replication by small interfering RNAs.
    Krönke J; Kittler R; Buchholz F; Windisch MP; Pietschmann T; Bartenschlager R; Frese M
    J Virol; 2004 Apr; 78(7):3436-46. PubMed ID: 15016866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of shRNA from a tissue-specific pol II promoter is an effective and safe RNAi therapeutic.
    Giering JC; Grimm D; Storm TA; Kay MA
    Mol Ther; 2008 Sep; 16(9):1630-6. PubMed ID: 18665161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus vectors lacking virus-associated RNA expression enhance shRNA activity to suppress hepatitis C virus replication.
    Pei Z; Shi G; Kondo S; Ito M; Maekawa A; Suzuki M; Saito I; Suzuki T; Kanegae Y
    Sci Rep; 2013 Dec; 3():3575. PubMed ID: 24356586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. All for one, one for all: new combinatorial RNAi therapies combat hepatitis C virus evolution.
    Grimm D
    Mol Ther; 2012 Sep; 20(9):1661-3. PubMed ID: 22945230
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of hepatitis C virus replication by intracellular delivery of multiple siRNAs by nanosomes.
    Chandra PK; Kundu AK; Hazari S; Chandra S; Bao L; Ooms T; Morris GF; Wu T; Mandal TK; Dash S
    Mol Ther; 2012 Sep; 20(9):1724-36. PubMed ID: 22617108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of hepatitis B virus antigen production and replication by wild-type HBV dependently replicating HBV shRNA vectors in vitro and in vivo.
    Li B; Sun S; Li M; Cheng X; Li H; Kang F; Kang J; Dörnbrack K; Nassal M; Sun D
    Antiviral Res; 2016 Oct; 134():117-129. PubMed ID: 27591142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of Combinatorial Lentiviral Vectors Expressing Multiple Anti-Hepatitis C Virus shRNAs and Their Validation on a Novel HCV Replicon Double Reporter Cell Line.
    Elbadawy HM; Mohammed Abdul MI; Aljuhani N; Vitiello A; Ciccarese F; Shaker MA; Eltahir HM; Palù G; Di Antonio V; Ghassabian H; Del Vecchio C; Salata C; Franchin E; Ponterio E; Bahashwan S; Thabet K; Abouzied MM; Shehata AM; Parolin C; Calistri A; Alvisi G
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32962117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Duplex shRNAs through a Lentiviral Vector against Cellular and Viral Genes Inflicts Sustained Inhibition of Hepatitis C Virus Replication.
    Mandal A; Chaubey B
    Intervirology; 2018; 61(2):79-91. PubMed ID: 30253401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of hepatitis C virus gene expression by adenoviral vectors encoding antisense RNA in vitro and in vivo.
    González-Carmona MA; Vogt A; Heinicke T; Quasdorff M; Hoffmann P; Yildiz Y; Schneider C; Serwe M; Bartenschlager R; Sauerbruch T; Caselmann WH
    J Hepatol; 2011 Jul; 55(1):19-28. PubMed ID: 21145870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo.
    Abe H; Imamura M; Hiraga N; Tsuge M; Mitsui F; Kawaoka T; Takahashi S; Ochi H; Maekawa T; Hayes CN; Tateno C; Yoshizato K; Murakami S; Yamashita N; Matsuhira T; Asai K; Chayama K
    J Hepatol; 2011 Jul; 55(1):11-8. PubMed ID: 21145867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alleviation of off-target effects from vector-encoded shRNAs via codelivered RNA decoys.
    Mockenhaupt S; Grosse S; Rupp D; Bartenschlager R; Grimm D
    Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4007-16. PubMed ID: 26170322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of hepatitis C virus RNA replication by short hairpin RNA synthesized by T7 RNA polymerase in hepatitis C virus subgenomic replicons.
    Hamazaki H; Ujino S; Miyano-Kurosaki N; Shimotohno K; Takaku H
    Biochem Biophys Res Commun; 2006 May; 343(3):988-94. PubMed ID: 16566896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical evaluation of an anti-HCV miRNA cluster for treatment of HCV infection.
    Yang X; Marcucci K; Anguela X; Couto LB
    Mol Ther; 2013 Mar; 21(3):588-601. PubMed ID: 23295950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.